Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies against carbonic anhydrase IX (CA IX) tumor antigen

Antibodies against carbonic anhydrase IX (CA IX) tumor antigen

US Patent 7378091 · Granted May 27, 2008

Estimated economic value: $99,152,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MAGEB2 binding constructs2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025
Human antigen binding proteins that bind β-klotho, FGF receptors and complexes t2024
Interleukin-2 muteins for the expansion of T-regulatory cells2024
ST2 antigen binding proteins2024
TIGIT and CD112R blockade2024
Anti-mesothelin binding proteins2024
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins2023
Interleukin-21 mutein/ anti-PD-1 antibody conjugates2023
Anti-PD-1 antibodies and methods of treatment2022
Targeted binding agents against B7-H12022
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022